RecruitingNCT05683093

Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy in Young Adulthood

Cardiovascular Longitudinal the Avon Longitudinal Study of Parents and Children (ALSPAC) Research Investigations Following Hypertensive Pregnancy in Young Adulthood


Sponsor

University of Oxford

Enrollment

200 participants

Start Date

Nov 17, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to understand more about why young people who were born to a hypertensive pregnancy may have increased risk of high blood pressure and are often at increased risk of heart and blood vessel disease later in life.


Eligibility

Min Age: 30 YearsMax Age: 40 Years

Inclusion Criteria5

  • Participant is willing and able to give informed consent for participation in the study
  • Male or female, aged 30 to 40 years at time of enrolment
  • Participant previously took part in the ALSPAC study
  • Able (in the investigator's opinion) and willing to comply with all study requirements
  • Adequate understanding of verbal and written English

Exclusion Criteria7

  • Pregnant or lactating when they are due to attend for study visit 1
  • Less than six months postpartum
  • Planning to donate blood within two weeks prior to study visit 1
  • Any significant disease or disorder which, in the opinion of the investigator, might influence the participant's ability to participate in the study
  • Evidence of congenital heart disease or significant chronic disease relevant to cardiovascular or metabolic status
  • For exclusion of MRI component only:
  • Unsuitable for MRI based on participant screening; the participant may still be included in other parts of the study

Interventions

OTHERHistory of being born to hypertensive or normal pregnancy

CLARITY is an observational study whereby participants will attend one 4-hr visit the Division of Cardiovascular Medicine, University of Oxford at the John Radcliffe Hospital in Oxford, with the option to split the study visit over two days for convenience. Participants will be invited by the ALSPAC study team to attend a study visit in Oxford where the investigators will use MRI and other imaging modalities to study the brain, heart, liver, kidneys, and vasculature using standardised protocols. A dataset including information from previous follow-up of these cohorts and the detailed pregnancy data available within ALSPAC will be generated by the study team in Bristol and integrated with available data from the Oxford cohorts.


Locations(1)

University of Oxford

Oxford, Oxfordshire, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05683093


Related Trials